The BROCADE 3 Study
November 14, 2016
Dr. Shannon Puhalla, Director, Breast Cancer Clinical Research Program, University of Pittsburgh Cancer Institute discusses the BROCADE 3 Study. Brocade3 is a research study evaluating the safety and effectiveness of an investigational medication in addition to treatment with chemotherapy for patients with metastatic or locally advanced BRCA associated, HER2-negative breast cancer.
People concerned about hereditary cancer, cancer survivors, previvors, and health care providers.